For: | Yu HS, Jiang H, Li MK, Yang BL, Smayi A, Chen JN, Wu B, Yang YD. Lowering the threshold of alanine aminotransferase for enhanced identification of significant hepatic injury in chronic hepatitis B patients. World J Gastroenterol 2023; 29(35): 5166-5177 [PMID: 37744292 DOI: 10.3748/wjg.v29.i35.5166] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v29/i35/5166.htm |
Number | Citing Articles |
1 |
Xue-Yan Yang, Xi-Dong Li, Bai-Yun Wu, Qiao Yang, Yu-Bao Zheng, Ming-Hua Zheng, Yin-Ping Wu, Hang-Yu Ma, Jing Zuo, Ruo-Xi Jia, Yue Yu, Ling-Yun Xu, Yu-Xin Tian, Qi An, Tao Zhang, Ying-Li He, Yu Shi, Yu-Chen Fan. A Model to Identify Gray Zone Patients With Chronic Hepatitis B Requiring Antiviral Therapy: A Multicenter Retrospective Study. The Journal of Infectious Diseases 2025; 232(2): 485 doi: 10.1093/infdis/jiaf070
|
2 |
Zi-Hong Bao, Zhi-Kun Dai, Hao-Xian Tang. Antiviral treatment standards for hepatitis B: An urgent need for expansion. World Journal of Gastroenterology 2024; 30(4): 418-420 doi: 10.3748/wjg.v30.i4.418
Abstract(794) |
Core Tip(885) |
Full Article(HTML)(1781)
|
Full Article with Cover (PDF)-770K(146)
|
Full Article (Word)-104K(18)
|
Audio-627K(11)
|
Peer-Review Report-197K(106)
|
Answering Reviewers-80K(111)
|
Full Article (PDF)-336K(178)
|
Full Article (XML)-30K(105)
|
Times Cited (2)
|
Total Visits (5843)
|
Open
|
3 |
Yen-Chun Liu, Wen-Juei Jeng. Should Indications for Antiviral Therapy for Hepatitis B Be Broadened to Include Immune-Tolerant Patients, Inactive Carriers, or Patients in the “Gray Zone”?. Current Hepatology Reports 2024; 23(1): 11 doi: 10.1007/s11901-024-00635-w
|
4 |
Hao Jiang, Hongsheng Yu, Yinan Huang, Mingkai Li, Bilan Yang, Xiaoli Xi, Yiming Lei, Bin Wu, Yidong Yang. Natural History and Prognosis of Chronic Hepatitis B Patients in the Indeterminate Phase. Journal of Gastroenterology and Hepatology 2025; 40(3): 720 doi: 10.1111/jgh.16849
|
5 |
Hongsheng Yu, Jianhao Wu, Mingkai Li, Can Hu, Yuexiang Ren, Hao Jiang, Yinan Huang, Yiming Lei, Jianning Chen, Bin Wu, Yidong Yang. Diagnostic and Prognostic Performance of the Agile 3+ Score in Patients With Chronic Hepatitis B and Concurrent MASLD After Complete Viral Suppression With Nucleos(t)ide Analogues. Journal of Gastroenterology and Hepatology 2025; doi: 10.1111/jgh.70099
|
6 |
Yuhua Gao, Mingyang Wang, Xia’nan Liu, Benjamin M. Liu. Noninvasive serum markers for predicting significant liver histopathology in HBeAg-negative chronic HBV-infected patients with normal alanine aminotransferase. Microbiology Spectrum 2024; 12(4) doi: 10.1128/spectrum.03941-23
|
7 |
Hongsheng Yu, Yinan Huang, Mingkai Li, Hao Jiang, Bilan Yang, Xiaoli Xi, Abdukyamu Smayi, Bin Wu, Yidong Yang. Prognostic significance of dynamic changes in liver stiffness measurement in patients with chronic hepatitis B and compensated advanced chronic liver disease. Journal of Gastroenterology and Hepatology 2024; 39(10): 2169 doi: 10.1111/jgh.16673
|
8 |
Dong Hyun Kim, Hye Won Lee. Letter on ‘Long‐Term Dynamic Changes of Alanine Aminotransferase Levels Are Associated With Liver‐Related Events in Nucleos(t)ide Analogue‐Treated Chronic Hepatitis B Patients in China’. Alimentary Pharmacology & Therapeutics 2025; doi: 10.1111/apt.70347
|